{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:38Z","timestamp":1786980338877,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00592-019-01461-z","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T05:15:38Z","timestamp":1576559738000},"page":"583-587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose tolerance"],"prefix":"10.1007","volume":"57","author":[{"given":"Chinmay S.","family":"Marathe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence G.","family":"Trahair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza K.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-5816","authenticated-orcid":false,"given":"Karen L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"issue":"9548","key":"1461_CR1","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","volume":"368","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368(9548):1696\u20131705. https:\/\/doi.org\/10.1016\/S0140-6736(06)69705-5","journal-title":"Lancet"},{"issue":"5","key":"1461_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2337\/db18-1123","volume":"68","author":"LS Gasbjerg","year":"2019","unstructured":"Gasbjerg LS, Helsted MM, Hartmann B et al (2019) Separate and combined glucometabolic effects of endogenous glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 in healthy individuals. Diabetes 68(5):906\u2013917. https:\/\/doi.org\/10.2337\/db18-1123","journal-title":"Diabetes"},{"issue":"1","key":"1461_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF02427280","volume":"29","author":"M Nauck","year":"1986","unstructured":"Nauck M, Stockmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29(1):46\u201352","journal-title":"Diabetologia"},{"issue":"2","key":"1461_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2337\/db17-0607","volume":"67","author":"DA Briere","year":"2018","unstructured":"Briere DA, Bueno AB, Gunn EJ, Michael MD, Sloop KW (2018) Mechanisms to elevate endogenous GLP-1 beyond injectable GLP-1 analogs and metabolic surgery. Diabetes 67(2):309\u2013320. https:\/\/doi.org\/10.2337\/db17-0607","journal-title":"Diabetes"},{"issue":"10","key":"1461_CR5","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.2337\/db14-0935","volume":"63","author":"S Madsbad","year":"2014","unstructured":"Madsbad S, Holst JJ (2014) GLP-1 as a mediator in the remission of type 2 diabetes after gastric bypass and sleeve gastrectomy surgery. Diabetes 63(10):3172\u20133174. https:\/\/doi.org\/10.2337\/db14-0935","journal-title":"Diabetes"},{"issue":"2","key":"1461_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00125-017-4447-4","volume":"61","author":"LS Gasbjerg","year":"2018","unstructured":"Gasbjerg LS, Christensen MB, Hartmann B et al (2018) GIP(3\u201330)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study. Diabetologia 61(2):413\u2013423. https:\/\/doi.org\/10.1007\/s00125-017-4447-4","journal-title":"Diabetologia"},{"issue":"10160","key":"1461_CR7","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/s0140-6736(18)32260-8","volume":"392","author":"JP Frias","year":"2018","unstructured":"Frias JP, Nauck MA, Van J et al (2018) Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet 392(10160):2180\u20132193. https:\/\/doi.org\/10.1016\/s0140-6736(18)32260-8","journal-title":"Lancet"},{"issue":"3","key":"1461_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.regpep.2004.06.020","volume":"122","author":"MA Nauck","year":"2004","unstructured":"Nauck MA, El-Ouaghlidi A, Gabrys B et al (2004) Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Regul Pept 122(3):209\u2013217. https:\/\/doi.org\/10.1016\/j.regpep.2004.06.020","journal-title":"Regul Pept"},{"issue":"Suppl 1","key":"1461_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/dom.13129","volume":"20","author":"MA Nauck","year":"2018","unstructured":"Nauck MA, Meier JJ (2018) Incretin hormones: Their role in health and disease. Diabetes Obes Metab 20(Suppl 1):5\u201321. https:\/\/doi.org\/10.1111\/dom.13129","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1461_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s10620-006-3187-y","volume":"51","author":"D Gentilcore","year":"2006","unstructured":"Gentilcore D, Doran S, Meyer JH, Horowitz M, Jones KL (2006) Effects of intraduodenal glucose concentration on blood pressure and heart rate in healthy older subjects. Dig Dis Sci 51(4):652\u2013656","journal-title":"Dig Dis Sci"},{"issue":"2","key":"1461_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0168-8227(97)00036-3","volume":"36","author":"JCN Chan","year":"1997","unstructured":"Chan JCN, Wong RYM, Cheung C-K et al (1997) Accuracy, precision and user-acceptability of self blood glucose monitoring machines. Diabetes Res Clin Pract 36(2):91\u2013104. https:\/\/doi.org\/10.1016\/S0168-8227(97)00036-3","journal-title":"Diabetes Res Clin Pract"},{"issue":"23","key":"1461_CR12","first-page":"738","volume":"106","author":"R Weitgasser","year":"1994","unstructured":"Weitgasser R, Straberger A, Schnoll F, Sailer S (1994) Clinical evaluation of the blood glucose monitors Accutrend, Companion 2, Glucometer 3 and One Touch II in comparison with the glucose oxidase reference method. Wien Klin Wochenschr 106(23):738\u2013741","journal-title":"Wien Klin Wochenschr"},{"issue":"7","key":"1461_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7%3C539::AID-DIA668%3E3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539\u2013553. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(199807)15:7%3C539::AID-DIA668%3E3.0.CO;2-S","journal-title":"Diabet Med"},{"issue":"11","key":"1461_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.14814\/phy2.12204","volume":"2","author":"LG Trahair","year":"2014","unstructured":"Trahair LG, Horowitz M, Marathe CS et al (2014) Impact of gastric emptying to the glycemic and insulinemic responses to a 75-g oral glucose load in older subjects with normal and impaired glucose tolerance. Physiol Rep 2(11):e12204. https:\/\/doi.org\/10.14814\/phy2.12204","journal-title":"Physiol Rep"},{"issue":"10","key":"1461_CR15","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/clinchem\/38.10.2156","volume":"38","author":"J Wishart","year":"1992","unstructured":"Wishart J, Morris HA, Horowitz M (1992) Radioimmunoassay of gastric inhibitory polypeptide in plasma. Clin Chem 38(10):2156\u20132157","journal-title":"Clin Chem"},{"issue":"3","key":"1461_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1210\/jc.2011-2583","volume":"97","author":"LG Trahair","year":"2012","unstructured":"Trahair LG, Horowitz M, Rayner CK et al (2012) Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects. J Clin Endocrinol Metabolism 97(3):844\u2013851","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1461_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1749-6632.2000.tb07017.x","volume":"921","author":"K Mortensen","year":"2000","unstructured":"Mortensen K, Petersen LL, Orskov C (2000) Colocalization of GLP-1 and GIP in human and porcine intestine. Ann N Y Acad Sci 921:469\u2013472","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1461_CR18","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1210\/endo-128-6-3175","volume":"128","author":"PL Brubaker","year":"1991","unstructured":"Brubaker PL (1991) Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128(6):3175\u20133182. https:\/\/doi.org\/10.1210\/endo-128-6-3175","journal-title":"Endocrinology"},{"issue":"1","key":"1461_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1172\/jci116186","volume":"91","author":"MA Nauck","year":"1993","unstructured":"Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91(1):301\u2013307. https:\/\/doi.org\/10.1172\/jci116186","journal-title":"J Clin Invest"},{"issue":"8","key":"1461_CR20","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.2337\/db13-1757","volume":"63","author":"CS Marathe","year":"2014","unstructured":"Marathe CS, Rayner CK, Bound M et al (2014) Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes. Diabetes 63(8):2668\u20132675. https:\/\/doi.org\/10.2337\/db13-1757","journal-title":"Diabetes"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01461-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T20:14:04Z","timestamp":1608063244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01461-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1461"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01461-z","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,17]]},"assertion":[{"value":"23 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CSM is supported by a NHMRC Early Career Fellowship, TW by a Royal Adelaide Hospital Florey Fellowship and KLJ by the University of Adelaide William T Southcott Research Fellowship.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human participants were in accordance with the ethical standards of the institutional research committee (Human Research Ethics Committee of the Royal Adelaide Hospital) and with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}